Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer

Inclusion Criteria: * Must meet one of the following: * The family contains at least two ovarian or breast cancers in the subject or first or second degree relatives of the subject. * The subject is of Ashkenazi Jewish ethnicity with one first degree or two second-degree relatives with breast or ovarian cancer, or subject is of Ashkenazi ancestry and has had breast cancer. * The subject has a male relative with breast cancer diagnosed at any age. * Probability of carrying a BRCA1/2 mutation given family pedigree of breast and ovarian cancers exceeds 20% (as determined by BRCAPRO 95% posterior probability interval). Exclusion Criteria: * Prior ovarian cancer or peritoneal carcinomatosis * A first or second degree relative with a BRCA1/2 mutation and has tested negative for exactly the same mutation. * The subject has no ovaries. * Less than 30 years of age, unless 25-30 with BRCA I or II mutation confirmed * Currently pregnant * Currently receiving adjuvant chemotherapy or radiation therapy for cancer (excluding tamoxifen). Patients who are being treated for local disease may enroll 3 months after completion of last treatment (excluding tamoxifen). * Treatment (excluding tamoxifen) for prior metastatic malignancy within the past five years. * Intraperitoneal surgery within the last 3 months.